Canada has now become a full member of JPIAMR, increasing the member count to 19.
Category: News and press
US “Antimicrobial ResistanceThreat Report 2013”
This report, Antibiotic resistance threats in the United States, 2013 gives a first-ever snapshot of the burden and threats posed by the antibiotic-resistant germs having the most impact on human health.
Each year in the United States, at least 2 million people become infected with bacteria that are resistant to antibiotics and at least 23,000 people die each year as a direct result of these infections. Many more people die from other conditions that were complicated by an antibiotic-resistant infection.
Antimicrobial resistance news feature in Nature
Antibiotic resistance: The last resort
Health officials are watching in horror as bacteria become resistant to powerful carbapenem antibiotics — one of the last drugs on the shelf.
China-Sweden Collaborative Workshop on Antibiotics and Resistance
The National Natural Science Foundation of China (NSFC) and the Swedish Research Council (SRC) sponsored a workshop in Beijing on May 15-17, 2013 to promote the exchange and collaboration between the Chinese and Swedish antibiotics resistance research communities. About 20 scientists from the two countries participated in this event that addressed antibiotics and their use on humans and animals as well as the environmental impacts of antibiotics. The Institute of Materia Medica, the Institute of Medicinal Biotechnology of CAMS/PUMS hosted and organized the workshop.
Keynote speeches addressed “the task forces against bacterial infection in China” (Professor Jiandong Jiang from the Institute of Materia Medica of CAMS/PUMC) and “the global challenge of antibiotics resistance” (Professor Mate Erdelyi from the Department of Chemistry and Molecular Biology, University of Gothenburg). These talks were complemented by 16 shorter presentations by researchers from both countries.
The workshop discussions presented a large number of thoughts on antibiotics resistance policy. These included more rigorous antibiotic stewardship in Chinese hospitals and the need for evidence based interventions aiming to improve rational use of antibiotics targeting all levels of the healthcare system as well as the community and use in animals. Evaluation of interventions should take into account behavioural change theories. The socio-economic impact of antibiotic resistance was acknowledged, as well as the impact on the environment. In-depth studies on the mechanism for antimicrobial resistance are needed. Folk and traditional natural products from Traditional Chinese Medicine and medicinal herbs from Africa or India are valuable and largely untapped resources for antibiotics enhancer to reduce the occurrence of antimicrobial resistance.
If you wish to participate in the SRA consultation please register for the Stakeholders Forum
SRA for community consultation
The current strategic research agenda (SRA) draft will be further developed according to the input and outcomes of the May 27-28 Geneva invitational conference. The resulting new draft will be made available to the public at this website no later than September 1, 2013. The research and stakeholder communities are most welcome to comment the SRA at this time.
Geneva Invitational Conference concluded
The JPIAMR Invitational Conference to discuss the strategic research agenda (SRA) was held in Geneva on May 27 and 28. Members from the management board, scientific advisory board and stakeholder advisory board, as well as additional experts, met for group and plenary discussions.
The constructive discussions have provided the SRA writers with a wealth of additional input to incorporate into the next SRA draft. We would like to thank all meeting participants for a productive conference!
JPIAMR-meeting in Geneva
An invitational conference will be held in Geneva on May 27-28.The main discussion topic will be the latest draft of the strategic research agenda (SRA). All members of the management board, the scientific advisory board and the stakeholder advisory board are invited, along with some additional experts.
First stakeholder meeting concluded
Stakeholder involvement will be crucial for the process of first developing and then implementing a strategic research agenda (SRA). A first stakeholder advisory board (SHAB) meeting was held at the Romanian Office for Science and Technology in Brussels on April 18 with representatives from Action on Antibiotic Resistance (ReACT), European Federation of Pharmaceutical Industries Associations (EFPIA), Federation of European Microbiological Societies (FEMS), Federation of Veterinarians of Europe (FVE), Standing Committee of European Doctors, and WHO Europe. The primary discussion topic was the recent SRA draft. Members of the SHAB will also participate in the upcoming JPIAMR invitational conference in Geneva.
Science advisory board chairman comments on India´s plan to tackle antimicrobial resistance
In the February issue of The Lancet Infectious Diseases Herman Goossens, chairman of JPIAMR’s scientific advisory board, comments on “The Chennai Declaration—a roadmap to tackle the challenges of antimicrobial resistance in India”.
